EMJ Podcast: Insights For Healthcare Professionals

In this episode, Anna Caldwell speaks with paediatric allergist and immunologist Zachary Rubin about the rise of medical misinformation, vaccine hesitancy, and the opportunities and challenges of social media in healthcare. They discuss common allergy myths, how clinicians can effectively communicate evidence-based medicine online, and what patients can do to prepare for the 2026 allergy season.

In this episode of Hema Now, Megan Melody speaks about the evolution of CAR-T cell therapy and its impact on lymphoma care. She explores the major advances that have transformed outcomes for patients with relapsed and refractory disease, the unanswered questions shaping current research, and the practical challenges of building successful cellular therapy programmes. The conversation also covers equitable access to treatment, the role of quality standards and accreditation, personalised approaches to CAR-T therapy, and the importance of physician leadership and mentorship in shaping the future of academic haematology.

Timestamps:

00:00 – Introduction

01:13 – Journey into Haematology and Lymphoma

04:19 – Major Advances in CAR-T

06:00 – Unanswered Questions After CAR-T

07:45 – Building Successful Cellular Therapy Programmes

09:06 – Improving Access to CAR-T

12:55 – Evolving Standards in Cellular Therapy

14:16 – Towards Personalised CAR-T Treatment

16:00 – Physician Leadership in Academic Medicine

17:10 – Career Advice for Future Specialists

19:02 – Future Directions in Cellular Therapy

What does the future hold for kidney stone management? In Part 3, David S. Goldfarb explores disparities in care, promising areas of research, and the move towards more personalised approaches to prevention and treatment. He also discusses the impact of climate change on kidney stone risk and shares why he remains optimistic about the future of kidney stone care.

Timestamps:

00:46 – Global warming

02:23 – Emerging research/treatments

03:57 – Asymptomatic kidney stones

04:58 – Broad, empiric approach to treatment

08:29 – Occupation as a risk factor for kidney stones

09:56 – Multidisciplinary care

11:51 – Climate change

13:47 – Calcium and kidney stones

What are the most effective ways to prevent kidney stones from recurring? In Part 2, David S. Goldfarb discusses evidence-based prevention strategies, including dietary counselling, hydration, and the role of pharmacological therapies.

In this episode of Onc Now, Vernon Sondak reflects on the remarkable evolution of melanoma care over the course of his career. He discusses how breakthroughs in surgery, immunotherapy, targeted therapies, and neoadjuvant treatment have transformed outcomes for patients with melanoma and influenced treatment strategies across oncology. The conversation also explores the challenges of paediatric melanoma, the importance of multidisciplinary collaboration, and the future priorities for melanoma research and patient care.

Timestamps:

00:00 – Introduction

01:30 - Melanoma Care Through the Years

06:52 - Sentinel Node Biopsy Impact Today

12:28 - Paediatric Melanoma Care Challenges

21:45 - Collaboration Driving Melanoma Progress

24:57 - Translating Research into Patient Care

31:30 - Exciting Advances in Systemic and Neoadjuvant Therapy

39:06 - Three Wishes for Melanoma Care

What causes kidney stones to form, and why are they becoming increasingly common? In Part 1, David S. Goldfarb explores the physiological mechanisms behind kidney stone disease, the evolving roles of diet, metabolism, and hydration, and the links between kidney stones and broader metabolic conditions, including metabolic syndrome and fatty liver disease. He also reflects on how advances in research have transformed our understanding of risk factors, genetics, and disease prevention.

In this quickfire episode, David S. Goldfarb answers key questions about kidney stone disease, from common misconceptions and risk factors to the roles of genetics, lifestyle, hydration, and prevention. He also discusses changing prevalence trends, and the steps clinicians and patients can take to reduce the burden of this increasingly common condition.

In the final episode, Salvatore Brugaletta explores the future of percutaneous coronary intervention, including AI-assisted decision-making, personalised device selection, and next-generation coronary therapies. Discover how innovation could further improve outcomes for patients with coronary artery disease.

Timestamps:

0:50 – 10 years from now

2:17 – AI

3:47 – Personalised medicine

5:34 – Breakthroughs

7:02 – Salvatore's vision

In Part 2, Salvatore Brugaletta discusses the rise, challenges, and future potential of bioresorbable vascular scaffolds. Learn how advances in material science are improving device performance, which patients may benefit most, and what emerging technologies could redefine coronary intervention.

Timestamps:

0:52 – Bioresorbable scaffold enthusiasm

3:16 – Which patients will benefit?

4:40 – Material Science Advancements

5:48 – Device Innovations

7:02 – Translational Hurdles

In this episode of Hema Now, Jorge Cortes reflects on the remarkable evolution of leukaemia treatment throughout his career, from the transformation of chronic myeloid leukaemia outcomes through targeted therapies to the rapidly changing landscape of acute myeloid leukaemia. He discusses the growing importance of biomarkers and patient-reported outcomes, the value of international collaboration, and how precision medicine is reshaping clinical research. Looking ahead, Cortes shares the developments in immunotherapy and personalised care that he believes could define the next era of leukaemia treatment.

Timestamps:

00:00 – Introduction

01:01 – Inspiration for Haematology and Leukaemia

02:40 – Transforming Chronic Myeloid Leukaemia Care

04:55 – Future Challenges in CML

07:21 – Evolution of AML Treatment

09:50 – Biomarkers and Personalised Leukaemia Care

11:45 – Balancing Outcomes and Quality of Life

14:02 – International Collaboration in CML

16:33 – The Future of Clinical Research

20:03 – Building a Haematology Academic Career

22:04 – Exciting Advances in Leukaemia Research